Novel CCR1 antagonists with oral activity in the mouse collagen induced arthritis
- 28 September 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (23) , 5160-5164
- https://doi.org/10.1016/j.bmcl.2005.08.057
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Novel CCR1 antagonists with improved metabolic stabilityBioorganic & Medicinal Chemistry Letters, 2004
- Potent small molecule CCR1 antagonistsBioorganic & Medicinal Chemistry Letters, 2004
- The discovery of structurally novel CCR1 antagonists derived from a hydroxyethylene peptide isostere templateBioorganic & Medicinal Chemistry Letters, 2004
- CP-481,715, a Potent and Selective CCR1 Antagonist with Potential Therapeutic Implications for Inflammatory DiseasesPublished by Elsevier ,2003
- Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2003
- A Non-peptide Functional Antagonist of the CCR1 Chemokine Receptor Is Effective in Rat Heart Transplant RejectionPublished by Elsevier ,2001
- J-113863Drugs of the Future, 2001
- Identification and Characterization of a Potent, Selective, and Orally Active Antagonist of the CC Chemokine Receptor-1Published by Elsevier ,2000
- 7-[3-(1-Piperidinyl)propoxy]chromenones as Potential Atypical AntipsychoticsJournal of Medicinal Chemistry, 1996
- Chemokine expression in murine experimental allergic encephalomyelitisJournal of Neuroimmunology, 1995